COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Cash Flow Analysis including operating cash flow, investing cash flow, financing cash flow, free cash flow, cash flow from operations, cash flow from investing, cash flow from financing. Compare cash flow against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Cash Flow Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.

Operating Cash Flow per Share

200.48

Increased from previous period

Operating Cash Flow per share above $10 – Remarkably strong. Warren Buffett would verify if this high level is consistent across cycles.

Free Cash Flow per Share

177.32

Increased from previous period

FCF/share above $5 – Strong leftover cash post-capex. Warren Buffett would examine reinvestment opportunities or dividends.

Capex-to-Operating Cash Flow

11.55%

Increased from previous period

Capex under 20% of OCF – Very capital-light. Warren Buffett would relish the strong free cash flows.

Income Quality Ratio (OCF / Net Income)

2.87

Increased from previous period

2–3 ratio – Very solid. Benjamin Graham would confirm no accounting distortions inflate net income.

Operating Cash Flow-to-Sales Ratio

14.74%

Increased from previous period

OCF-to-sales 10–15% – Moderate. Peter Lynch might look for operational tweaks to improve cash flow.

Select Chart Metric:

3349.T Cash Flow Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Operating Cash Flow per Share

200.48

Increased from previous period

Operating Cash Flow per share above $10 – Remarkably strong. Warren Buffett would verify if this high level is consistent across cycles.

Free Cash Flow per Share

177.32

Increased from previous period

FCF/share above $5 – Strong leftover cash post-capex. Warren Buffett would examine reinvestment opportunities or dividends.

Capex-to-Operating Cash Flow

11.55%

Increased from previous period

Capex under 20% of OCF – Very capital-light. Warren Buffett would relish the strong free cash flows.

Income Quality Ratio (OCF / Net Income)

2.87

Increased from previous period

2–3 ratio – Very solid. Benjamin Graham would confirm no accounting distortions inflate net income.

Operating Cash Flow-to-Sales Ratio

14.74%

Increased from previous period

OCF-to-sales 10–15% – Moderate. Peter Lynch might look for operational tweaks to improve cash flow.

Select Chart Metric: